Mechanisms of action of the bisphosphonates

Medicina

Volumn 57, Issue SUPPL. 1, 1997, Pages 65-75

  Fleisch, Herbert ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

bisphosphonates; mechanism of action

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; CLODRONIC ACID; EB 1053; ETIDRONIC ACID; IBANDRONIC ACID; INCADRONIC ACID; NERIDRONIC ACID; OLPADRONIC ACID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; BONE TUMOR; CALCIFICATION; DRUG MECHANISM; DRUG STRUCTURE; HUMAN; HYPERPARATHYROIDISM; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; OSTEOPOROSIS; PAGET BONE DISEASE; RAT; REVIEW;

ANIMALS; BONE DENSITY; BONE RESORPTION; CALCINOSIS; DIPHOSPHONATES; HUMANS; OSTEOCLASTS; OSTEOPOROSIS; RATS;

EID: 0030754322     PISSN: 00257680     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (65)

1. Ammann P, Rizzoli R, Caverzasio J, et al. Effects of the bisphosphonate tiludronate on bone resorption, calcium balance, and bone mineral density. J Bone Miner Res 1993; 8: 1491-1498
2. Azuma Y, Sato H, Oue Y, et al. Alendronate distributed on bone surfaces inhibits osteoclastic bone resorption in vitro and in experimental hypercalcemic models. Bone 1995; 16: 235-245.
3. Balena R, Toolan BC, Shea M, et al. The effects of 2-year treatment with the aminobisphosphonate alendronate on bone metabolism, bone histomorphometry, and bone strength in ovariectomized nonhuman primates. J Clin Invest 1993; 92: 2577-2586.
4. Bonekamp PM, van der Wee-Pals LJA, van Wijkvan Lennep MML, et al. Two modes of action of bisphosphonates on osteoclastic resorption of mineralized matrix. Bone Miner 1986; 1: 27-39.
5. Boyce RW, Paddock CL, Gleason JR, et al. The effects of risedronate on canine cancellous bone remodeling: three-dimensional kinetic reconstruction of the remodeling site. J Bone Miner Res 1995; 10: 211-221.
6. Briner WW, Francis MD, Widder, JS. The control of dental calculus in experimental animals. Int Dent J 1971; 21: 61-73.
7. Ciosek CP Jr., Magnin DR, Harrity TW, et al. Lipophilic 1,1-bisphosphonates are potent squalene synthase inhibitors and orally active cholesterol lowering agents in vivo. J Biol Chem 1993; 268: 24832-24837.
8. David P, Nguyen H, Barbier H, Baron R. Tiludronate is a potent and specific inhibitor of the osteoclast vacuolar H'ATPase. Bone (Tarrytown) 1995; 16: 166S.
9. Evēquoz V, Trechsel U, Fleisch, H. Effect of bisphosphonates on production of interleukin 1-like activity by macrophages and its effect on rabbit chondrocytes. Bone 1985; 6: 439-444.
10. Fast DK, Felix R, Dowse C. The effects of diphosphonates on the growth and glycolysis of connective-tissue cells in culture. Biochem J 1978; 172: 97-107.
11. 14C]1-hydroxyethlidene-1,1-bisphospo-nate in cultured calvaria cells. Calcif Tissue Int 1984; 36: 108-113.
12. Ferretti JL, Delgado CJ, Capozza RF, et al. Protective effects of disodium etidronate and pamidronate against the biochemical repercussion of beta-methasone-induced osteopenia in growing rat femurs. Bone Miner 1993; 20: 265-276.
13. 2MBP-coated bone. Bone Miner 1989; 6: 33-43.
14. 45Ca kinetics in the intact rat. Osteopor Int 1996; 6: 166-170.
15. Fleisch H. Bisphosphonates: Mechanisms of action and clinical use. In: Principles of Bone Biology. JP Bilezikian, LG Raisz, GA Rodan (eds.) Academic Press San Diego London, 1996: pp. 1037-1052.
16. Fleisch, H. Bisphosphonates in bone disease. From the laboratory to the patient. Third Edition, The Parthenon Publishing Group Ltd., Carnforth, New York; 1997.
17. Fleisch H, Russell RGG, Bisaz S, et al. The influence of pyrophosphate analogues (diphosphonates) on the precipitation and dissolution of calcium phosphate in vitro and in vivo. Calcif Tiss Res 1968; 2(Suppl.): 10-10a.
18. Fleisch H, Russell RGG, Bisaz S, et al. The inhibitory effect of phosphonates on the formation of calcium phosphate crystals in vitro and on aortic and kidney calcification in vivo. Eur J Clin Invest 1970; 1: 12-18.
19. Fieisch H, Russell RGG, Francis M.D. Diphosphonates inhibit hydroxyapatite dissolution in vitro and bone resorption in tissue culture and in vivo. Science 1969; 165: 1262-1264.
20. Fleisch H, Russell RGG, Straumann F. Effect of pyrophosphate on hydroxyapatite and its implications in calcium homeostasis. Nature 1966; 212: 901-903.
21. Francis MD. The inhibition of calcium hydroxyapa-tite crystal growth by polyphosphonates and polyphosphates. Calcif Tissue Res 1969; 3: 151-162.
22. Francis MD, Hovancik K, Boyce RW. NE-58095: A diphosphonate which prevents bone erosion and preserves joint architecture in experimental arthritis, Int J Tissue React 1989; 11: 239-252.
23. Francis MD, Russell RGG, Fleisch H. Diphosphonates inhibit formation of calcium phosphate crystals in vitro and pathological calcification in vivo. Science 1969; 165: 1264-1266.
24. Gasser AB, Morgan DB, Fleisch HA, Richelle, L.J. The influence of two diphosphonates on calcium metabolism in the rat. Clin Sci 1972; 43: 31-45.
25. Geddes AD, D'Souza SM, Ebetino FH, Ibbotson KJ. Bisphosphonates: structure-activity relationships and therapeutic implications. In: Heersche JNM, Kanis JA (eds.) Bone and mineral research. Elsevier Amsterdam 1994; pp. 265-306.
26. Giuliani N, Girasole G, Pedrazzoni M, et al. Alendronate stimulates β-FGF production and mineralized nodule formation in human osteoblastic cells and osteoblastogenesis in human bone marrow cultures. J Bone Miner Res 1995; 10(Suppl. 1): S171, Abstract 129.
27. Green JR, Müller K, Jaeggi KA. Preclinical pharmacology of CGP 42,446, a new, potent, heterocyclic bisphosphonate compound. J Bone Miner Res 1994; 9: 745-751.
28. Guenther HL, Guenther HE, Fleisch H. The effects of 1-hydroxyethane-1,1-diphosphonate and dichloromethanediphosphonate on collagen synthesis by rabbit articular chondrocytes and rat bone cells. Biochem J 1981; 196: 293-301.
29. Guenther HL, Guenther HE, Fleisch H. The influence of 1-hydroxyethane-1,1-diphosphonate and dichloromethanediphosphonate on lysine hydroxylation and cross-link formation in rat bone, cartilage and skin collagen. Biochem J 1981; 196: 303-310.
30. Hughes DE, MacDonald BR, Russell RGG, Gowen M. Inhibition of osteoclast-like cell formation by bisphosphonates in long-term cultures of human bone marrow. J Clin Invest 1989; 83: 1930-1935.
31. Hughes DE, Wright KR, Uy HL, et al. Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo. J Bone Miner Res 1995; 10: 1478-1487.
32. Jee WSS. Black HE, Gotcher JE. Effect of dichloromethane diphosphonate on cortisol-induced bone loss in young adult rabbits. Clin Orthop 1981; 156: 39-51.
33. Jung A, Bisaz S, Fleisch H. The binding of pyrophosphate and two diphosphonates by hydroxyapatite crystals. Calcif Tiss Res 1973; 11: 269-280.
34. Jung A, Bornand J, Mermillod B, Edouard C, Meunier PJ. Inhibition by diphosphonates of bone resorption induced by the Walker tumor of the rat. Cancer Res 1984; 44: 3007-3011.
35. King WR, Francis MD, Michael WR. Effect of disodium ethane-1-hydroxy-1,1-diphosphonate on bone formation. Clin Orthop 1971; 78: 251-270.
36. Lin JH, Chen I-W, DeLuna FA. Nonlinear kinetics of alendronate. Plasma protein binding and bone uptake. Drug Metab Dispos 1994; 22: 400-405.
37. Martodam RR, Thornton KS, Sica DA, D'Souza SM, Flora L, Mundy GR. The effects of dichloromethylene diphosphonate on hypercalcemia and other parameters of the humoral hypercalcemia of malignancy in the rat Leydig cell tumor. Calcif Tissue Int 1983; 35. 512-519.
38. 3H-etidronate in rat and mouse bones. Bone 1996; 19: 281-290.
39. Menschutkin N. Ueber die Einwirkung des Chloracetyls auf phosphorige Säure. Ann Chem Pharm 1865; 133: 317-320.
40. Motoie H, Nakamura T, O'uchi N. et al. Effects of the bisphosphonate YM175 on bone mineral density, strength, structure, and turnover in ovariectomized beagles on concomitant dietary calcium restriction. J Bone Miner Res 1995; 10: 910-920.
41. Murakami HN, Takahashi T, Sasaki N. et al. A possible mechanism of the specific action of bisphosphonates on osteoclasts: tiludronate preferentially affects polarized osteoclasts having ruffled borders. Bone (Tarrytown) 1995; 17: 137-144.
42. Mühlbauer RC, Bauss F, Schenk R.et al. BM 21.0955, a potent new bisphosphonate to inhibit bone resorption. J Bone Miner Res 1991; 6: 1003-1011.
43. Nishikawa M, Akatsu T, Katayama Y. et al. Bisphosphonates act on osteoblastic cells and inhibit osteoclast formation in mouse marrow cultures. 1996; 18: 9-14.
44. Osterman T, Kippo K, Laurén L, Hannuniemi R, Sellman R. Effect of clodronate on established adjuvant arthritis. Rheumatol Int 1994; 14: 139-147.
45. Plaasmans CMT, Jap PHK, Kuypers W., Slooff TJJ. Influence of a diphosphonate on the cellular aspect of young bone tissue. Calcif Tissue Int 1980; 32: 247-256.
46. Reynolds JJ, Minkin C, Morgan DB, Spycher D, Fleisch H. The effect of two diphosphonates on the resorption of mouse calvaria in vitro. Calcif Tiss Res 1972; 10: 302-313.
47. Rodan GA, Fleisch HA. Bisphosphonates: mechanisms of action. J Clin Invest 1996; 97: 2692-2696.
48. Russell RGG, Mühlbauer RC, Bisaz S, William, DA, Fleisch H. The influence of pyrophosphate, condensed phosphates, phosphonates and other phosphate compounds on the dissolution of hydroxyapatite in vitro and on bone resorption induced by parathyroid hormone in tissue culture and in thyroparathyroidectomized rats. Calcif Tiss Res 1970; 6: 183-196.
49. Sahni M, Guenther HL, Fleisch H, et al. Bisphosphonates act on rat bone resorption through the mediation of osteoblasts. J Clin Invest 1993; 91: 2004-2011.
50. Sato M, Grasser W. Effects of bisphosphonates on isolated rat osteoclasts as examined by reflected light microscopy. J Bone Miner Res 1990; 5: 31-40.
51. Sato M, Grasser W, Endo N, Akins R, Simmons H, Thompson DD, Golub E, Rodan GA. Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure. J Clin Invest 1991; 88: 2095-2105.
52. Schenk R, Eggli P, Fleisch H, Rosini S. Quantitative morphometric evaluation of the inhibitory activity of new aminobisphosphonates on bone resorption in the rat. Calcif Tissue Int 1986; 38: 342-349.
53. 2MDP) on the calcification and resorption of cartilage and bone in the tibial epiphysis and metaphysis of rats. Calcif Tiss Res 1973; 11: 196-214.
54. Schmidt A, Rutledge SJ, Endo N, et al. Proteintyrosine phosphatase activity regulates osteoclast formation and function: inhibition by alendronate. Proc Natl Acad Sci USA 1996; 93: 3068-3073.
55. Shinoda H, Adamek G, Felix R, Fleisch H, Schenk R, Hagan P. Structure-activity relationships of various bisphosphonates. Calcif Tissue Int 1983; 35: 87-99.
56. Storm T, Steiniche T, Thamsborg G, Melsen F. Changes in bone histomorphometry after long-term treatment with intermittent, cyclic etidronate for postmenopausal osteoporosis. J Bone Miner Res 1993; 8: 199-208.
57. Toolan BC, Shea M, Myers ER, et al. Effects of 4-amino-1-hydroxybutylidene bisphosphonate on bone biomechanics in rats. J Bone Miner Res 1992; 7: 1399-1406.
58. Trechsel U, Schenk R, Bonjour J-P, Russell RGG, Fleisch H. Relation between bone mineralization, Ca absorption, and plasma Ca in phosphonatetreated rats Am J Phyiol 1977; 232: E298-E305.
59. Trechsel U, Stutzer A, Fleisch H. Hypercalcemia induced with an retinoid in thyroparathyroidectomized rats. A new model to study bone resorption in vivo. J Clin Invest 1987; 80: 1679-1686.
60. Tsuchimoto M, Azuma Y, Higuchi O, et al. Alendronate modulates osteogenesis of human osteoblastic cells in vitro. Jpn J Pharmacol 1994; 66: 25-33.
61. Vitté C, Fleisch H, Guenther HL. Osteoblasts mediate the bisphosphonate inhibition on bone resorption through synthesis of an osteoclast-inhibiting activity. J Bone Min Res 1994; 9 (Suppl.1): S142, Abstract 87.
62. Von Baeyer H, Hofmann KA. Acetodiphosphorige Säure. Ber Dtsch Chem Ges 1897; 30: 1973-1978.
63. Wiedmer WH, Zbinden AM, Trechsel U, Fleisch H. Ultrafiltrability and chromatographic properties of pyrophosphate, 1-hydroxyethylidene-1,1-bisphosphonate, and dichloromethylenebisphosphonate in aqueous buffers and in human plasma. Calcif Tissue Int 1983; 35: 397-400.
64. Wronski TJ, Dann LM, Qi H, Yen CF. Skeletal effects of withdrawal of estrogen and diphosphonate treatment in ovariectomized rats. Calcif Tissue Int 1993; 53: 210-216.
65. Zimolo Z, Wesolowski G, Rodan GA. Acid extrusion is induced by osteoclast attachment to bone: inhibition by alendronate and calcitonin. J Clin Invest 1995; 96: 2277-2283.